Refining classification of cholangiocarcinoma subtypes via proteogenomic integration reveals new therapeutic prospects

Intrahepatic cholangiocarcinomas (iCCs) are characterized by their rarity, difficult diagnosis, and overall poor prognosis. The iCC molecular classification for developing precision medicine strategies was investigated.